PREDICTION OF LOW DISEASE ACTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH SECUKINUMAB IN REAL WORLD - DATA FROM THE GERMAN AQUILA STUDY

被引:0
|
作者
Vodencarevic, A. [1 ]
Brandt-Juergens, J. [2 ]
Peterlik, D. [1 ]
Gmeiner, B. [1 ]
Kiltz, U. [3 ]
机构
[1] Novartis Pharma GmbH, Novartis, Nurnberg, Germany
[2] Schwerpunktpraxis, Rheumatol, Berlin, Germany
[3] Herne & Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany
关键词
Real-world evidence; Spondyloarthritis; Artificial Intelligence;
D O I
10.1136/annrheumdis-2023-eular.229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OP0058
引用
收藏
页码:38 / 38
页数:1
相关论文
共 50 条
  • [1] Prediction of Low Disease Activity in Patients with Ankylosing Spondylitis Treated with Secukinumab in Real World - Data from a German Observational Study
    Vodencarevic, Asmir
    Brandt-Juergens, Jan
    Peterlik, Daniel
    Gmeiner, Benjamin
    Kiltz, Uta
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2725 - 2727
  • [2] PREDICTION OF LOW DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH SECUKINUMAB IN REAL WORLD - DATA FROM THE GERMAN AQUILA STUDY
    Vodencarevic, A.
    Brandt-Juergens, J.
    Peterlik, D.
    Gmeiner, B.
    Kiltz, U.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1126 - 1126
  • [3] DOES SMOKING AFFECT SECUKINUMAB TREATMENT OUTCOMES AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY
    Riechers, E.
    Kiltz, U.
    Brandt-Juergens, J.
    Kaestner, P.
    Peterlik, D.
    Tony, H. P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 729 - 729
  • [4] Prediction of Low Disease Activity in Patients with Psoriatic Arthritis Treated with Secukinumab in Real World - Data from a German Observational Study
    Vodencarevic, Asmir
    Brandt-Juergens, Jan
    Peterlik, Daniel
    Gmeiner, Benjamin
    Kiltz, Uta
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 953 - 954
  • [5] AQUILA STUDY IN GERMANY - REAL WORLD DATA ON SECUKINUMAB'S EFFECTIVENESS IN ANKYLOSING SPONDYLITIS PATIENTS - RESULTS FROM AN INTERIM ANALYSIS
    Kiltz, Uta
    Peterlik, Daniel
    Winkelmann, Veronika
    Tony, Hans-Peter
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 890 - 890
  • [6] HOW DOES GENDER AFFECT SECUKINUMAB TREATMENT OUTCOMES AND RETENTION RATES IN PATIENTS WITH ANKYLOSING SPONDYLITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY
    Kiltz, U.
    Brandt-Juergens, J.
    Kaestner, P.
    Riechers, E.
    Peterlik, D.
    Tony, H. P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 706 - 707
  • [7] HOW DOES BODY MASS INDEX AFFECT SECUKINUMAB TREATMENT OUTCOMES AND SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY
    Kiltz, U.
    Brandt-Juergens, J.
    Kastner, P.
    Riechers, E.
    Peterlik, D.
    Budden, C.
    Tony, H. P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1500 - 1501
  • [8] REAL WORLD EXPERIENCE OF THE IMPACT OF SECUKINUMAB ON DISEASE ACTIVITY AND FATIGUE IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Batool, S.
    Bawa, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1608 - 1608
  • [9] HOW DOES TIME TO DIAGNOSIS AND GENDER AFFECT TREATMENT OUTCOMES IN PATIENTS WITH ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY WITH SECUKINUMAB
    Benesova, K.
    Hansen, O.
    Kiltz, U.
    Brandt-Juergens, J.
    Kastner, P.
    Riechers, E.
    Peterlik, D.
    Budden, C.
    Boas, A.
    Welle, S.
    Tony, H. P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1501 - 1502
  • [10] Uveitis Status in Patients with Ankylosing Spondylitis or Psoriatic Arthritis Under Secukinumab Treatment - Real World Data from a German Observational Study
    Kiltz, Uta
    Brandt-Jrgens, Jan
    Kaestner, Peter
    Riechers, Elke
    Peterlik, Daniel
    Boas, Annika
    Tony, Hans-Peter
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3621 - 3623